Background Non-compliance rates with antipsychotic medication can be high, and the personal and societal costs are considerable.
A new psychological intervention, compliance therapy seeks to improve compliance and patient outcomes and reduce treatment costs.
Method A randomised controlled study examined the cost-effectiveness of compliance therapy compared to non-specific counselling over 18 months for 74 people with psychosis admitted as in-patients at the Maudsley Hospital.
Bivariate and multivariate analyses were conducted to test for differences and to explore inter-patient cost variations.
Results Compliance therapy is more effective and is no more expensive.
Consequently, compliance therapy is more cost-effective than non-specific counselling at six, 12 and 18 months.
Conclusions There are compliance, outcome and cost-effectiveness arguments in favourofcompliance therapy in preference to non-specific counselling.
Mots-clés Pascal : Psychose, Chimiothérapie, Neuroleptique, Psychotrope, Observance médicamenteuse, Observance thérapeutique, Traitement, Motivation, Cognition, Analyse coût, Utilisation, Service santé, Economie santé, Santé mentale, Angleterre, Grande Bretagne, Royaume Uni, Europe, Homme
Mots-clés Pascal anglais : Psychosis, Chemotherapy, Neuroleptic, Psychotropic, Drug compliance, Treatment compliance, Treatment, Motivation, Cognition, Cost analysis, Use, Health service, Health economy, Mental health, England, Great Britain, United Kingdom, Europe, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0317806
Code Inist : 002B02B03. Création : 27/11/1998.